Loading...

Improvement of Blood Plasmalogens and Clinical Symptoms in Parkinson's Disease by Oral Administration of Ether Phospholipids: A Preliminary Report

Introduction. Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease (AD). With the ageing of population, the frequency of PD is expected to increase dramatically in the coming decades. L-DOPA (1,3,4-dihydroxyalanine) is the most effective dr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Parkinsons Dis
Main Authors: Mawatari, Shiro, Ohara, Shinji, Taniwaki, Yoshihide, Tsuboi, Yoshio, Maruyama, Toru, Fujino, Takehiko
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049862/
https://ncbi.nlm.nih.gov/pubmed/32148751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/2671070
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!